Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack F Shern

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
JAMA Network Open|March 28, 2024
Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma: A Report From the Children's Oncology GroupBailey A Martin-Giacalone, He Li, Michael E Scheurer, et al.
Molecular Cancer Therapeutics|April 22, 2026
NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibitionAngela Kim, Prateek Bhardwaj, Shahyan Rehman, et al.
Cancer Genetics|May 3, 2016
Current state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshopPooja Hingorani, Katherine Janeway, Brian D Crompton, et al.
Cancer Research|August 22, 2019
Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing SarcomaChoh Yeung, Anna E Gibson, Sameer H Issaq, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2021
Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International ConsortiumJack F Shern, Joanna Selfe, Elisa Izquierdo, et al.
Medrxiv : the Preprint Server for Health Sciences|January 31, 2024
Early detection of malignant and pre-malignant peripheral nerve tumors using cell-free DNA fragmentomicsR Taylor Sundby, Jeffrey J Szymanski, Alexander Pan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2024
Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA FragmentomicsR Taylor Sundby, Jeffrey J Szymanski, Alexander C Pan, et al.
Nature Communications|February 24, 2024
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcomaYong Yean Kim, Berkley E Gryder, Ranuka Sinniah, et al.
Pediatric Blood & Cancer|June 22, 2019
Insights into pediatric rhabdomyosarcoma research: Challenges and goalsMarielle E Yohe, Christine M Heske, Elizabeth Stewart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2023
The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric CancerJoseph A Flores-Toro, Subhashini Jagu, Gregory T Armstrong, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
JAMA Network Open|March 28, 2024
Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma: A Report From the Children's Oncology GroupBailey A Martin-Giacalone, He Li, Michael E Scheurer, et al.
Molecular Cancer Therapeutics|April 22, 2026
NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibitionAngela Kim, Prateek Bhardwaj, Shahyan Rehman, et al.
Cancer Genetics|May 3, 2016
Current state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshopPooja Hingorani, Katherine Janeway, Brian D Crompton, et al.
Cancer Research|August 22, 2019
Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing SarcomaChoh Yeung, Anna E Gibson, Sameer H Issaq, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2021
Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International ConsortiumJack F Shern, Joanna Selfe, Elisa Izquierdo, et al.
Medrxiv : the Preprint Server for Health Sciences|January 31, 2024
Early detection of malignant and pre-malignant peripheral nerve tumors using cell-free DNA fragmentomicsR Taylor Sundby, Jeffrey J Szymanski, Alexander Pan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2024
Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA FragmentomicsR Taylor Sundby, Jeffrey J Szymanski, Alexander C Pan, et al.
Nature Communications|February 24, 2024
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcomaYong Yean Kim, Berkley E Gryder, Ranuka Sinniah, et al.
Pediatric Blood & Cancer|June 22, 2019
Insights into pediatric rhabdomyosarcoma research: Challenges and goalsMarielle E Yohe, Christine M Heske, Elizabeth Stewart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2023
The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric CancerJoseph A Flores-Toro, Subhashini Jagu, Gregory T Armstrong, et al.
Pageof 10